[Possibilities and limitations of intravenous anesthesia]

[Possibilities and limitations of intravenous anesthesia] Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

[Possibilities and limitations of intravenous anesthesia] Abstract Text:

H D Kamp,B Naujoks,G Geisslinger,

The increasing importance of intravenous anaesthesia is based on two developments, namely the synthesis of substances capable of acting selectively and over the short term, and which are rapidly eliminated (good control), and a desire on the part of the anaesthetist to have an anaesthetic whose actions can be controlled in various ways. Efforts in this area are aimed at ensuring not only a minimum of stressing of organs by the anaesthetic, but also a minimisation of risks during the intra-operative phase, and a non-problematic maximally pleasant post-operative course. There are two problems that militate against the realization of these objectives. Although the substances presented here ideally permit the realization of some of these aims, at the same time they are associated with side effects that prevent their use from ever being completely non-problematical, and which should always prompt the exercise of particular care when employing these medications. In addition, the differentiable control made possible by the use of these drugs is (partly) offset by inadequate monitoring with respect to the qualities of the anaesthetic--a fact that modifies the potential advantages of intravenous anaesthesia.

[Possibilities and limitations of intravenous anesthesia] Publishing Authors By Initials

HD Kamp,B Naujoks,G Geisslinger,

For similar organic chemicals: phenols: propofol research abstracts see: organic chemicals: phenols: propofol research

PUBMED ID PMID:

MEDLINE DATE:

[Possibilities and limitations of intravenous anesthesia] Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Therapeutische Umschau. Revue thérapeutique

VOLUME: 48

Page Numbers: 388-94

Journal Abbreviation:

ISSN: 0040-5930

DAY: 12

MONTH: Jun

YEAR: 1991

[Possibilities and limitations of intravenous anesthesia] Information

Number of References:

LANGUAGE: ger

NlmUniqueID: 407224

[Possibilities and limitations of intravenous anesthesia] Keywords Mesh Terms:

KEYWORDS: Propofol

MESH TERMS: classification

Chemical & Substance for Abstract: [Possibilities and limitations of intravenous anesthesia] Information

Substance Name: Ketamine

Registry Number: 6740-88-1

Grant and Affiliation Information for [Possibilities and limitations of intravenous anesthesia]

AFFILIATION: Institut für Anästhesiologie, Universität Erlangen-Nürnberg.

Country: SWITZERLAND

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Ther Umsch

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Possibilities and limitations of intravenous anesthesia Related Publications

• Celecoxib inhibits 5-lipoxygenase.
• Consequences of altered eicosanoid patterns for nociceptive processing in mPGES-1-deficient mice.
• Genetic polymorphism of the type A human natriuretic peptide receptor (NPR-A) gene contributes to the interindividual variability in the BNP system.
• Proteomics in neuropathic pain research.
• The IKK-NF-kappaB pathway: a source for novel molecular drug targets in pain therapy?
• [Possibilities and limitations of intravenous anesthesia]
• cGMP produced by NO-sensitive guanylyl cyclase essentially contributes to inflammatory and neuropathic pain by using targets different from cGMP-dependent protein kinase I.